This inventor holds 1 USPTO granted patent. Top assignee: Yungjin Pharameutical Ind. Co., Ltd.. Active years: 2001.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2001
Title: The Innovative Contributions of Dong Jin Seo
Introduction
Dong Jin Seo is a notable inventor based in Kyungki-do, South Korea. He has made significant contributions to the field of pharmaceuticals, particularly in the production of cholesterol-lowering agents. His work has implications for the treatment of hypercholesterolemia, a condition affecting many individuals worldwide.
Latest Patents
Dong Jin Seo holds a patent for a method for producing pravastatin precursor, ML-236B. This invention relates to a new method for producing ML-236B, specifically the lactone form, free acid form, and sodium salt form by utilizing a new microorganism isolated from soil. The ML-236B is obtained from the culture broth of this microorganism and serves as a substrate for pravastatin sodium, which is a potent cholesterol-lowering agent.
Career Highlights
Dong Jin Seo is associated with Yungjin Pharmaceutical Industries Co., Ltd., where he continues to innovate in the pharmaceutical sector. His work has been instrumental in advancing methods for producing essential compounds used in medical treatments.
Collaborations
He has collaborated with notable colleagues, including Kae Jong Chung and Joo Kyung Lee, contributing to the advancement of their shared goals in pharmaceutical research and development.
Conclusion
Dong Jin Seo's innovative work in the production of pravastatin precursor highlights his significant role in the pharmaceutical industry. His contributions are vital for developing effective treatments for hypercholesterolemia, showcasing the importance of innovation in healthcare.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile